欢迎来到喀斯玛汇智科技服务平台

服务热线: 010-82648522

首页 > 专利推荐 > 专利详情

Quinazoline derivative and application thereof

  • 申请号:US201214241067
  • 专利类型:US
  • 申请(专利权)人:中国科学院福建物质结构研究所
  • 公开(公开)号:US9193718(B2)
  • 公开(公开)日:2015.11.24
  • 法律状态:
  • 出售价格: 面议
  • 立即咨询

专利详情

专利名称 Quinazoline derivative and application thereof
申请号 US201214241067 专利类型 US
公开(公告)号 US9193718(B2) 公开(授权)日 2015.11.24
申请(专利权)人 中国科学院福建物质结构研究所 发明(设计)人 Lu Canzhong;Yong Jianping
主分类号 A61K31/517 IPC主分类号 A61K31/517;C07D413/12;C07D413/06
专利有效期 Quinazoline derivative and application thereof 至Quinazoline derivative and application thereof 法律状态
说明书摘要 This invention provides a class of quinazoline compounds, as represented by formula (I), and their pharmaceutically acceptable salts,;wherein: each of R1 and R2 independently, is selected from H, C1-C6 alkoxy, halo-C1-C6 alkoxy, C1-C6-alkoxy-C1-C6 alkoxy, C3-C8 cycloalkoxy, C3-C8 heterocycloalkoxy containing at least one of heteroatoms selected from N, O, S; Z is —NR4—, C(R5)2, S or —O—, wherein R4 is H or C1-C3 alkyl, R5 is the same or different, selected from H or C1-C3 alkyl; R3 is selected from H, halogen, C1-C6 alkyl, C1-C6 alkoxy or halo-C1-C6 alkyl; n is an integer from 0 to 5. This invention also provides methods of preparation and medical uses of the compounds of formula (I) and their pharmaceutically acceptable salts. These compounds have the activity of inhibiting EGFR-TK, and can be used as drugs for the treatment of protein tyrosine kinase related diseases such as tumors, cancers, etc.

交易流程

  • 01 选取所需
    专利
  • 02 确认专利
    可交易
  • 03 签订合同
  • 04 上报材料
  • 05 确认变更
    成功
  • 06 支付尾款
  • 07 交付证书

平台保障

1、源头对接,价格透明

2、平台验证,实名审核

3、合同监控,代办手续

4、专员跟进,交易保障

  • 用户留言
暂时还没有用户留言

求购专利

专利交易流程

  • 01 选取所需专利
  • 02 确认专利可交易
  • 03 签订合同
  • 04 上报材料
  • 05 确认变更成功
  • 06 支付尾款
  • 07 交付证书
官方客服(周一至周五:8:30-17:30) 010-82648522